📰 Translation Sciences News
Page 3 - Translation Sciences News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Translation Sciences. Real-time updates on events, politics, business and more.
October 10, 2021
Scientists at University of Utah Health made a discovery that could lead to a new way to treat Parkinsons disease and potentially stop its progression.
February 10, 2021
E-Mail DALLAS, Feb. 10, 2021 — Reducing the prevalence of obesity may prevent up to half of new Type 2 diabetes cases in the United States, according to new research published today in the Journal of the American Heart Association, an open access journal of the American Heart Association. Obesity is a major contributor to diabetes, and the new study suggests more tailored efforts are needed to reduce the incidence of obesity-related diabetes. Type 2 diabetes is the most common form of dia...
January 11, 2021
E-Mail WINSTON-SALEM, N.C. - Jan. 11, 2021 - Most doctors would agree that advanced care planning (ACP) for patients, especially older adults, is important in providing the best and most appropriate health care over the course of a patients life. Unfortunately, the subject seldom comes up during regular clinic visits. In a study conducted by doctors at Wake Forest Baptist Health, only 3.7% of primary care physicians had this conversation with their patients as part of their normal care. Yet...
December 19, 2020
Get the latest industry news first when you subscribe to our daily newsletter. We will never sell or share your information without your consent. See our privacy policy.
December 17, 2020
Expert panel votes FDA SHOULD give Modernas COVID-19 vaccine emergency approval amid hopes the U.S will soon have a second shot to help get 20 million Americans vaccinated by the end of 2020 A panel of FDA experts voted that the agency should approve Modernas coronavirus vaccine and recommend whether the shot should be approved With their endorsement, Modernas shot will almost certainly get emergency approval tonight or tomorrow Two people in Modernas trial had severe allergic reactions:�...